Showing results (161-170 of 288) with videos related to

Sort By:
Pageof 29
The New England Journal of Medicine|May 12, 2021
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled AsthmaAndrew Menzies-Gow, Jonathan Corren, Arnaud Bourdin, et al.
The Lancet. Respiratory Medicine|April 1, 2022
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 studyMichael E Wechsler, Andrew Menzies-Gow, Christopher E Brightling, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Switching to twice-yearly depemokimab from mepolizumab/benralizumab in severe asthma: A multicenter, randomized, double-blind, Phase 3A Clinical Trial (NIMBLE)Geoffrey Chupp, Hiroyuki Nagase, Dirk Skowasch, et al.
The Journal of Allergy and Clinical Immunology|November 16, 2025
Transient early blood eosinophil increases do not affect dupilumab's long-term efficacy in patients with moderate-to-severe asthmaIan D Pavord, Njira L Lugogo, Mario Castro, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 28, 2026
Early and Sustained Efficacy of Depemokimab in Type 2 Asthma: A Pooled Analysis of the SWIFT-1/-2 StudiesMichael E Wechsler, Ian D Pavord, Reynold A Panettieri, et al.
Pharmacoepidemiology and Drug Safety|September 24, 2004
Identification of patients with Churg-Strauss syndrome (CSS) using automated dataLeslie R Harrold, Susan E Andrade, Mark Eisner, et al.
Allergy|August 17, 2021
From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseasesIan D Pavord, Elisabeth H Bel, Arnaud Bourdin, et al.
Respiratory Medicine|April 24, 2022
Characteristics and outcomes of ambulatory patients with suspected COVID-19 at a respiratory referral centerVamsi P Guntur, Brian D Modena, Laurie A Manka, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 17, 2018
Association of free vitamin D<sub>3</sub> concentrations and asthma treatment failures in the VIDA TrialJohn J Lima, Mario Castro, Tonya S King, et al.
Advances in Therapy|May 27, 2024
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR StudyTara F Carr, Wendy C Moore, Monica Kraft, et al.
Pageof 29